GLYCOMIRA, LLC

Company Information
Address 675 ARAPEEN DR, STE 302
SALT LAKE CITY, UT, 84108-1228


Information

DUNS: 827444345

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis

    Amount: $297,614.00

    PROJECT SUMMARY This proposal aims to develop a therapeutic capable of preventing and treating the severe sinus inflammation associated with chronic rhinosinusitis CRS CRS is a debilitating inflamm ...

    SBIRPhase I2016Department of Health and Human Services
  2. Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis

    Amount: $746,312.00

    ABSTRACT Oral mucositis is a devastatingly painful inflammatory disease that frequently develops during cancer therapy and affects half a million people in the US The accompanying pain is so severe ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  3. Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis

    Amount: $199,997.00

    DESCRIPTION (provided by applicant): GlycoMira Therapeutics has developed safe and effective anti-inflammatory glycosaminoglycan derivatives and proposes to test the feasibility of using its lead com ...

    SBIRPhase I2014Department of Health and Human Services
  4. Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis

    Amount: $1,500,000.00

    DESCRIPTION (provided by applicant): Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults. In the most severely affected, progression of th ...

    SBIRPhase II2013Department of Health and Human Services
  5. Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis

    Amount: $1,507,000.00

    DESCRIPTION provided by applicant Chronic gingival inflammation of the soft tissue surrounding the tooth afflicts over half of all American adults In the most severely affected progression of th ...

    SBIRPhase II2013Department of Health and Human Services National Institutes of Health
  6. Novel Glycosaminoglycan Ethers for Prevention of Metastasis

    Amount: $210,000.00

    DESCRIPTION (provided by applicant): Heparin and its derivatives block P- and L-selectin mediated metastatic spread of cancer in animal models, and they potently inhibit the matrix degrading enzyme he ...

    SBIRPhase I2011Department of Health and Human Services
  7. Anti-Inflammatory Glycosaminoglycan Ethers for Treatment of Periodontitis

    Amount: $210,000.00

    DESCRIPTION (provided by applicant): Chronic gingival inflammation afflicts over half of all American adults and can progress to periodontal disease, eventually resulting in tooth loss. Periodontitis ...

    SBIRPhase I2011Department of Health and Human Services
  8. Novel Glycosaminoglycan Derivatives for Treatment of Bladder Inflammation

    Amount: $200,024.00

    DESCRIPTION (provided by applicant): Painful bladder syndrome/interstitial cystitis (PBS/IC) is an indolent bladder disorder that has continued to be a debilitating disease with few truly effective tr ...

    SBIRPhase I2011Department of Health and Human Services
  9. Sulfated Polysaccharide Derivatives for the Treatment of Rosacea

    Amount: $149,800.00

    DESCRIPTION (provided by applicant): Rosacea is a common disfiguring skin disease affecting 3% of the population over 30 years of age, or 14 million Americans. In men and women of Celtic origin, Rosa ...

    SBIRPhase I2009Department of Health and Human Services
  10. Sulfated Polysaccharide Derivatives for Treatment of Macular Degeneration

    Amount: $140,000.00

    DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is a leading cause of blindness in the U.S., affecting 8 million Americans over fifty years of age. Its cause is rooted in t ...

    SBIRPhase I2009Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government